Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: Targeting SNHG3/miR-186-5p reverses the increased m6A level caused by platinum treatment through regulating METTL3 in esophageal cancer

Fig. 1

a Expression of SNHG3 in 348 esophageal cancer patients. b Expression of miR-186-5p in 348 esophageal cancer patients. c Expression of SNHG3 in recurrence and non-recurrence groups. d Expression of miR-186-5p in recurrence and non-recurrence groups. e Expression of METTL3, METTL14, FTO and ALKBH5 in 348 esophageal cancer patients. f Expression of METTL3, METTL14, FTO and ALKBH5 in recurrence and non-recurrence groups. g Expression of SNHG3 in esophageal cancer cells. h Expression of miR-186-5p in esophageal cancer cells

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us